London: Promising results from a trial of a new stem-cell based therapy
for a rare and debilitating skin condition have been published in the
Journal of Investigative Dermatology.
The therapy, involving infusions of stem cells, was found to provide
pain relief and to reduce the severity of this skin condition for which
no cure currently exists. RDEB (
recessive dystrophic epidermolysis bullosa) is a painful skin disease in which very minor skin injury
leads to blisters and poorly healing wounds. About 1,000 people in the
UK live with RDEB.
